MS368

General

Cell Line

hPSCreg name ITXi003-A
Cite as:
ITXi003-A (RRID:CVCL_B5Q8)
Alternative name(s)
MS368
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
SCVIi061-A
(SCVI2149C1)
Donor diseases:
Long QT Syndrome
SCVIi062-A
(SCVI2150c1)
Donor diseases:
Long QT Syndrome
ITXi004-A
(MS381)
Donor diseases:
Long QT Syndrome
YUCMi022-A
(hiPSC-KCNH2_G53S)
Donor diseases:
Long QT Syndrome
ZJUi010-A
(ZJULLi002-A, 161103SPYLQTFSDC12)
Donor diseases:
Long QT Syndrome
SCVIi097-A
(SCVI-675fs2)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi098-A
(SCVI-675fs3)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi099-A
(SCVI-675fs4)
Donor diseases:
Hypertrophic Cardiomyopathy
CCMi012-A
(LMNA_SP_C3)
Donor diseases:
Dilated Cardiomyopathy
SCVIi050-A
(SCVI2486)
Donor diseases:
Dilated Cardiomyopathy
BRCi021-A
(TUH1)
Donor diseases:
Cardiomyopathy
ISMMSi044-A
(PLNR14del-1BC1)
Donor diseases:
Cardiomyopathy
ISMMSi045-A
(PLNR14del-2BC4)
Donor diseases:
Cardiomyopathy
ISMMSi047-A
(PLN-R14del-4AC4)
Donor diseases:
Cardiomyopathy
ISMMSi048-A
(PLN-R14del-5BC4)
Donor diseases:
Cardiomyopathy
SCVIi037-A
(SCVI672)
Donor diseases:
hypertrophic cardiomyopathy
UKKi035-A
(NP0139-A, NP0139-3E)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-B
(NP0139-B, NP0139-6C)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-C
(NP0139-C, NP0139-24D)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
FAMRCi009-A
(RCMP43)
Donor's gene variants:
FLNC
Donor diseases:
Restrictive Cardiomyopathy
FAMRCi011-A
(ARVC51)
Donor's gene variants:
FLNC
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
YCMi009-A
(YCMi009-hDCM009-A)
Donor diseases:
dilated cardiomyopathy
ICGi028-A
(HCM4fm5.2)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-A
(F81 (940) clone 5)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-B
(F81 (940) clone 8)
Donor diseases:
Hypertrophic Cardiomyopathy
FAMRCi011-B
(ARVC51b)
Donor's gene variants:
FLNC
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
IBBISTi007-A
(6F26)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi007-B
(2F26)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi096-A
(SCVI-675fs1)
Donor diseases:
Hypertrophic Cardiomyopathy
ISMMSi046-A
(PLN-R14del-3BC7)
Donor diseases:
Cardiomyopathy
SCVIi073-A
(SCVIi574C2)
Donor's gene variants:
titin, BAG cochaperone 3, BAG cochaperone 3
Donor diseases:
Dilated Cardiomyopathy
SCVIi074-A
(SCVIi599C1)
Donor's gene variants:
BAG cochaperone 3
Donor diseases:
Hypertrophic Cardiomyopathy
PUMCHi002-A
(20180908R-AE3, PUMCH-IRC)
Donor diseases:
Restrictive Cardiomyopathy
FAMRCi006-A
(LMNA T3)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
Last update 2nd February 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator l’institut du thorax (ITX)

External Databases

BioSamples SAMEA11025523
Cellosaurus CVCL_B5Q8
Wikidata Q111733531

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Ethnicity European

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Catecholamine-Induced QT Prolongation (CIQTP)
The donor is affected.
Synonyms
  • Ventricular arrhythmia associated with long QT syndrome
  • Long QT Syndrome
  • LONG QT SYNDROME

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes
SNP typing array
Normal male karyotype with no aneuploidies detected

External Databases (Donor)

BioSamples SAMEA12775560

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? No
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Open Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? MESRI and CPP Ouest II
Approval number Autorisation IE 2009-505(1) ; MESR n° DC-2011-1399; Autorisation CPP 46/11
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
RT-PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
O2 Concentration 21 %
CO2 Concentration 5 %
Medium Other medium:
Base medium: StemMACS™ iPS-Brew XF
Main protein source:
Serum concentration: %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
TRA 1-60
Yes
SSEA-1
No
SSEA-4
Yes
SOX2
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
HAND1
Yes
Ectoderm
Ont Id: NCIT_C12703
In vitro spontaneous differentiation
Marker Expressed
PAX6
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XY
Passage number: 19
Karyotyping method: Molecular karyotyping by SNP array

Other Genotyping (Cell Line)

Is there genome-wide genotyping or functional data available?
Yes
SNP typing array